Studies on drug release in vitro and rat intestinal absorption of tashinone IIA solid lipid nanoparticles

Chinese Pharmacological Bulletin

Volumn 21, Issue 2, 2005, Pages 186-190

  Liu, Jian Ping ^a   Du, Zhi Yong ^a   Zhu, Li ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Drug release in vitro; Intestinal absorption characteristic; Solid lipid nanoparticles; Tashinone IIA

Indexed keywords

SOLID LIPID NANOPARTICLE; TASHINONE IIA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; COLON; DRUG ABSORPTION; DRUG RELEASE; INTESTINE; INTESTINE ABSORPTION; NONHUMAN; RAT; SUSTAINED RELEASE PREPARATION;

EID: 17144364276     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Barthel L, Woodley J, Houin G. Gastrointestinal absorption of drugs; Methods and atudies [J]. Fundam Clin Pharmacol, 1999, 13 (2):154-68.
2. Schurgers N, Bijdendijk J, Tuleleer JJ. Comparison of four experimental techniques for studying drug absorption kinetics in the anesthetized rat in situ [J]. J Pharm Sci, 1986, 75(2):117-9.
3. Sutton SC, Rinaldi MT, McCarthy JM. A statistical method for the determineation of absorption rate constant estimated using the rat single pass intestinal perfusion model and multiple linear regression [J]. J Pharm Sci, 2002, 91(4):1046-53.
4. Jung T, Kamm W, Breitenbach A et al. Biodegradable nanoparticle for oral of peptides [J]. Eur J Pharm Biopharm, 2000, 50(1): 147-60.
5. Florence AT. The oral absorption of micro-and nonoparticulates neither exceptional nor unusual [J]. Pharm Res, 1997, 14(3): 259-66.